Abstract
Plasma renin activity (PRA) was studied before and during long-term treatment with moderate oral doses (0.2 or 0.3 mg/d) of clonidine. Nine outpatients with essential hypertension received clonidine for 12 weeks; a significant decrease in blood pressure was evident in all patients. Except for a nonsignificant increase after 12 weeks of treatment, PRA values were not notably changed by clonidine therapy. No correlation was found between individual blood pressure changes and PRA variation during the study. The absence of a net effect on PRA in this study does not exclude more complex interactions of clonidine with the renin-angiotensin system. Nonetheless, clonidine cannot generally be classified as a "renin-inhibiting" drug.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Haber E., Koerner T., Page L. B., Kliman B., Purnode A. Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. J Clin Endocrinol Metab. 1969 Oct;29(10):1349–1355. doi: 10.1210/jcem-29-10-1349. [DOI] [PubMed] [Google Scholar]
- Hökfelt B., Hedeland H., Dymling J. F. Studies on catecholamines, renin and aldosterone following Catapresan (2-(2,6-dichlor-phenylamine)-2-imidazoline hydrochloride) in hypertensive patients. Eur J Pharmacol. 1970;10(3):389–397. doi: 10.1016/0014-2999(70)90212-8. [DOI] [PubMed] [Google Scholar]
- Kobinger W., Walland A. Evidence for a central activation of a vagal cardiodepressor reflex by clonidine. Eur J Pharmacol. 1972 Aug;19(2):203–209. doi: 10.1016/0014-2999(72)90010-6. [DOI] [PubMed] [Google Scholar]
- Laragh J. H. Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles. Am J Med. 1973 Sep;55(3):261–274. doi: 10.1016/0002-9343(73)90128-9. [DOI] [PubMed] [Google Scholar]
- Turner W. J., Merlis S. Vicissitudes in research: the twenty-four hour urine collection. Clin Pharmacol Ther. 1971 Mar-Apr;12(2):163–166. doi: 10.1002/cpt1971122part1163. [DOI] [PubMed] [Google Scholar]
- van Zwieten P. A. The central action of antihypertensive drugs, mediated via central alpha-receptors. J Pharm Pharmacol. 1973 Feb;25(2):89–95. doi: 10.1111/j.2042-7158.1973.tb10599.x. [DOI] [PubMed] [Google Scholar]